Navigation Links
Global Anticoagulants Industry
Date:12/5/2012

>

Table 44: German Historic Review for Anticoagulants by

Product Segment - Oral Anticoagulants and Injectable

Anticoagulants (Unfractionated Heparin and Low Molecular

Weight Heparin) Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2004 through 2009

(includes corresponding Graph/Chart) III-36

 

Table 45: German 15-Year Perspective for Anticoagulants by

Product Segment - Percentage Breakdown of Dollar Sales for

Oral Anticoagulants and Injectable Anticoagulants

(Unfractionated Heparin and Low Molecular Weight Heparin)

Markets for the Years 2004, 2011 & 2018 (includes

corresponding Graph/Chart) III-37

 

3c. ITALY III-38

A.Market Analysis III-38

Outlook III-38

B.Market Analytics III-39

Table 46: Italian Recent Past, Current & Future Analysis for

Anticoagulants by Product Segment - Oral Anticoagulants and

Injectable Anticoagulants (Unfractionated Heparin and Low

Molecular Weight Heparin) Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2010

through 2018 (includes corresponding Graph/Chart) III-39

 

Table 47: Italian Historic Review for Anticoagulants by

Product Segment - Oral Anticoagulants and Injectable

Anticoagulants (Unfractionated Heparin and Low Molecular

Weight Heparin) Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2004 through 2009

(includes corresponding Graph/Chart) III-40

 

Table 48: Italian 15-Year Perspective for Anticoagulants by

Product Segment - Percentage Breakdown of Dollar Sales for

Oral Anticoagulants and Injectable Anticoagulants

(Unfractionated Heparin and Low Molecular Weight Heparin)

Markets for the Years 2004, 2011 & 2018 (includes

corresponding Graph/Chart)
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine technology :

1. Global Operating Tables Industry
2. Global Proteomics Industry
3. Global Neurostimulation Industry
4. Global Audiological Devices Industry
5. Global Condoms Industry
6. Sophono Names Global Sales and Marketing Vice President
7. Global Chitin and Chitosan Industry
8. Global Sleep Apnea Diagnostic And Therapeutic Devices Industry
9. Global Market for Medical Device Electrodes to Reach $1.43 billion, Technological Innovations and Developing Markets Fuel Demand for Neurological Monitoring and Digital Radiography
10. Global Market for Molecular Diagnostics to Exceed $10.7 Billion by 2018, Regenerative Medicine to Top $4.4 Billion
11. Global Bioinformatics Market is Expected to Reach USD 9.1 Billion in 2018: Transparency Market Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 2014  Aethlon Medical, Inc. (OTCQB:AEMD), announced today that ... approximately $3.3 million at a price of $0.30 per ... focused investor. Each unit consists of one common share ... warrant. Each whole warrant entitles the holder to acquire ... a period of five years from closing.  ...
(Date:11/26/2014)... Texas , Nov. 26, 2014 ... today announced the completion of previously announced concurrent ... million.  After fees and estimated offering expenses, Lexicon ... the transactions.  The transactions consisted of: ... common stock, pursuant to a registration statement that ...
(Date:11/26/2014)... -- Investor-Edge has initiated coverage on the following ... PLC (NASDAQ: HZNP ), Endocyte Inc. (NASDAQ: ... ), and Theravance Inc. (NASDAQ: THRX ). Free ... http://investor-edge.com/register . On Tuesday, November 25, 2014, the ... Industrial Average edged 0.02% lower, to finish the day at ...
Breaking Medicine Technology:Aethlon Medical Announces $3.3 Million Equity Investment 2Aethlon Medical Announces $3.3 Million Equity Investment 3Lexicon Announces Completion Of $280 Million In Financing Transactions 2Lexicon Announces Completion Of $280 Million In Financing Transactions 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5
(Date:11/28/2014)... 28, 2014 Dr. Andrew Campbell, one ... announced the expansion of Quintessa Aesthetic Center into a ... located at W307 N1497 Golf Road in Suite 200 ... Dr. Campbell, the new Delafield location will offer a ... patients, including: Botox, filler injectables , micro laser ...
(Date:11/28/2014)... 2014 The Alternative Health ... the past five years. The industry has been ... that are either alternative to conventional Western medicine ... industry analyst David Whytcross, “industry revenue has been ... private health insurance membership.” Meanwhile, improving economic conditions ...
(Date:11/28/2014)... News) -- Planning on seconds at Thanksgiving Day dinner ... known as gastroesophageal reflux disease (GERD) -- a few steps ... ear, nose and throat specialist at Lenox Hill Hospital in ... GERD on Thanksgiving: Pace yourself. Rather ... meals throughout the day. It,s also a good idea to ...
(Date:11/28/2014)... 28, 2014 An inventor and dental assistant ... a patient’s filling and it was almost impossible to reach. ... light," she said. , The patent-pending Access Light allows for ... to areas of the mouth, as well as avoids harm ... safety. Easy to use and clean, it also helps prevent ...
(Date:11/28/2014)... 2014 A newly released article ... of the influenza virus that will soon be spreading across ... The article begins with a brief explanation of what the ... reminds families that children under the age of 5, adults ... diseases, such as heart and lung diseases, asthma, or diabetes, ...
Breaking Medicine News(10 mins):Health News:Dr. Andrew Campbell to Expand Quintessa Aesthetic Center into Delafield 2Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:Don't Let Chronic Heartburn Spoil Your Thanksgiving Feast 2Health News:How Flu Vaccines Can Impact Families Is Discussed in New Article from Community Health Center of Snohomish County 2
... increase in Social Security Disability Insurance recipients; time-intensive process of receiving ... Allsup , ... Belleville, Ill. (Vocus) June 25, 2008 ... Insurance (SSDI) benefits continued to grow in 2007. This means ...
... The National Intelligence Council (NIC) has completed a new ... U.S. security in the next 20 years by causing ... over water and other resources in specific countries. The ... June 25, on the main findings. , ...
... are the workhorses of our cells. They help to digest ... and literally shape our body from top to toe. Proteins ... of enzymes, which are important in the creation of anything ... possibilities are virtually without limit. , To take advantage ...
... of venous thromboembolism, study finds , , WEDNESDAY, June 25 ... rivaroxaban helps prevent potentially fatal blood clots after hip ... of venous thromboembolism (VTE) is high after total hip ... leaves hospital. Current guidelines recommend patients receive a heparin-based ...
... Pharmavite, a leader in the,dietary ... consumer-centric,program, LearnSomethingAbout(TM), as a partner in ... consumer-oriented multimedia,program that seamlessly integrates into ... "LearnSomething shares similar goals with Pharmavite ...
... MedeFile,International, Inc. (OTC Bulletin Board: MDFI), a company ... announced,that a highly exclusive, membership only, resort community ... memberships and is offering,MedeFile,s full suite of products ... 1,400 members., Members who subscribe to MedeFile,s ...
Cached Medicine News:Health News:SSDI Recipients Ask: When Do I Get My Benefits? 2Health News:SSDI Recipients Ask: When Do I Get My Benefits? 3Health News:Climate change may challenge national security, classified report warns 2Health News:Climate change may challenge national security, classified report warns 3Health News:1 step closer to green chemistry and improved pharmaceuticals 2Health News:Oral Drug Helps Prevent Clotting After Hip Replacement 2Health News:Pharmavite Partners With LearnSomething, Inc. on Consumer Education Program, LearnSomethingAbout(TM) 2Health News:Exclusive Resort Community Looks to MedeFile to Provide Members With Access to Medical Records Anytime, Anywhere 2
Attain Left-heart Lead Delivery Systems. Medtronic offers left-heart lead delivery systems to assist with accessing the coronary sinus (cs)....
... The Attain™ Deflectable Catheter - designed ... using a single catheter. Steerablility - Create ... procedure with a single, steerable guide catheter. ... desired shape to address each patient's unique ...
Attain LV Leads. Navigate minimally angled veins with little to moderate tortuosity....
... The Hancock® II bioprosthesis from ... years of proven clinical experience. ... the freedom from structural valve ... and mitral bioprostheses is substantially ...
Medicine Products: